Nolan Advised Transnetyx on its Acquisition of Laragen

ACQUIRED BY

“I believe Laragen is a perfect fit for Transnetyx. Transnetyx has built highly accurate, automated testing solutions and a cohesive distribution network, which will allow us to provide researchers unparalleled access to Laragen’s enhanced sequencing services.”

Bob Bean
Bob Bean
CEO, Transnetyx

  • Transnetyx is a global leader in outsourced genetic services and a portfolio company of Thompson Street Capital Partners.
  • Founded in 2000 and headquartered in Memphis, TN, Transnetyx focuses on enabling researchers to control for biological variability in their experiments, facilitating ethical and responsible research practices.
  • Transnetyx offers a full suite of tools that advance scientific research reproducibility and replicability and provides evidence-based education and thought leadership to promote the advancement of laboratory practices.
  • Transnetyx hired Nolan due to our long-standing relationship with Thompson Street Capital Partners, and expertise in the laboratory services market.
  • Laragen provides sequencing, genotyping, and other laboratory services for genomics research to leading government, pharmaceutical, and academic research institutes.
  • The acquisition of Laragen furthers the Transnetyx mission to ensure that every researcher in the world has the most efficient path to discovery.
  • The addition of Sanger sequencing and next-generation sequencing (NGS) services to the Transnetyx solution suite will ultimately improve access to cutting-edge genetic services for leading research institutes around the world.
  • To view more details about this deal, please view the press release here.

Featured Case Studies

ACQUIRED BY
ACQUIRED BY
ACQUIRED BY
ACQUIRED BY
ACQUIRED BY
ACQUIRED BY
ACQUIRED BY
ACQUIRED BY